You have access
Prognostic Stratification of the IMDC Intermediate Risk Group After Treatment With First-line Molecular-targeted Therapy for Metastatic Renal Cell Carcinoma
KIYOSHI TAKAHARA, RYOSUKE ANDO, KENT KANAO, TOSHIKI ITO, HIDEAKI MIYAKE, MAKOTO SUMITOMO, TAKAHIRO YASUI and RYOICHI SHIROKI
Anticancer Research August 2020, 40 (8) 4395-4400; DOI: https://doi.org/10.21873/anticanres.14443